Stakeholder perspectives regarding pragmatic clinical trial collateral findings
Abstract Context Pragmatic clinical trials (PCTs), which are becoming widespread since they are relatively inexpensive and offer important benefits for healthcare decision‐making, can also present practical, ethical, and legal challenges. One such challenge involves managing "pragmatic clinical...
Saved in:
Main Authors: | Stephanie R. Morain (Author), Debra J. H. Mathews (Author), Kevin Weinfurt (Author), Elizabeth May (Author), Juli M. Bollinger (Author), Gail Geller (Author), Jeremy Sugarman (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stakeholder perspectives on data sharing from pragmatic clinical trials: Unanticipated challenges for meeting emerging requirements
by: Stephanie R. Morain, et al.
Published: (2024) -
Prioritization of ethical concerns regarding HIV molecular epidemiology by public health practitioners and researchers
by: Anne L. R. Schuster, et al.
Published: (2024) -
Certificates of confidentiality and unexpected complications for pragmatic clinical trials
by: Jeremy Sugarman, et al.
Published: (2021) -
Post‐trial responsibilities in pragmatic clinical trials: Fulfilling the promise of research to drive real‐world change
by: Stephanie R. Morain, et al.
Published: (2024) -
The Collateral Impacts of Pandemic
by: Ceva Wicaksono Pitoyo
Published: (2020)